Search results for "Color"

showing 10 items of 2721 documents

Rectal cancer: Assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI

2012

Purpose To assess pretreatment functional and morphological tumor characteristics with magnetic resonance imaging (MRI) in advanced rectal carcinoma and to identify factors predicting response to neoadjuvant chemoradiation. Materials and Methods In a prospective study, 95 patients with rectal carcinoma underwent dynamic contrast-enhanced MRI before and after chemoradiation. Quantitative parameters were derived from a pharmacokinetic two-compartment model. Tumors were also characterized with regard to mucinous status at pretreatment high-resolution MRI as nonmucinous or mucinous. Response to treatment was defined as a downshift in the local tumor stage. Results The parameter k21 (contrast me…

Oncologymedicine.medical_specialtymedicine.diagnostic_testColorectal cancerbusiness.industryMagnetic resonance imagingOdds ratiomedicine.diseaseContrast mediumInternal medicineDynamic contrast-enhanced MRImedicineMucinous carcinomaRadiology Nuclear Medicine and imagingMucinous TumorNuclear medicinebusinessProspective cohort studyJournal of Magnetic Resonance Imaging
researchProduct

KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issue.

2009

Background: Cetuximab and panitumumab, mAbs targeting EGFR, are registered for metastatic colorectal carcinoma (mCRC) patients whose tumors express EGFR as determined by immunohistochemistry. However, this method is not predictive of treatment efficacy. KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene, encodes a small G-protein that functions downstream of EGFR-induced signalling. Objective/Methods: To examine KRAS mutations as predictive factors of response to anti-EGFR mAbs using recently published data. Results/conclusions: Several retrospective studies show that efficacy of these mAbs is confined to patients with wild type KRAS and genotyping of tumors should be consi…

Oncologymedicine.medical_specialtymedicine.drug_classColorectal cancerClinical BiochemistryPopulationCetuximabMonoclonal antibodymedicine.disease_causeAntibodies Monoclonal HumanizedProto-Oncogene Proteins p21(ras)Internal medicineProto-Oncogene ProteinsDrug DiscoverymedicinePanitumumabAnimalsHumansKRAScolorectal carcinomaeducationneoplasmsGenotypingPharmacologyeducation.field_of_studyClinical Trials as TopicCetuximabbusiness.industryPanitumumabAntibodies Monoclonalmedicine.diseasedigestive system diseasesErbB ReceptorsMutationCancer researchras ProteinsImmunohistochemistryKRASbusinessColorectal Neoplasmsmedicine.drugExpert opinion on biological therapy
researchProduct

Impact of Postoperative Complications on Survival and Recurrence After Resection of Colorectal Liver Metastases

2019

OBJECTIVE To study the effect of postoperative complications (POC) on overall survival (OS) and disease-free survival (DFS) after surgical resection of colorectal liver metastases (CRLM). SUMMARY BACKGROUND DATA Morbidity rates after liver resection can reach 45%. The negative impact of POC on oncologic outcomes has been reported in various types of cancer, especially colorectal. However, data on the consequences of POC after CRLM resection on long-term survival are scarce. METHODS Eligible studies examining the association between POC after CRLM resection and OS/DFS were sought using the PubMed and Web of Science databases. A random-effects model was used to calculate pooled effect estimat…

Oncologymedicine.medical_specialtymedicine.medical_treatmentSubgroup analysisResection03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicinemedicineHepatectomyHumansSurvival rateSurvival analysisbusiness.industryLiver NeoplasmsHazard ratioCancermedicine.diseaseSurvival Rate030220 oncology & carcinogenesisMeta-analysis030211 gastroenterology & hepatologySurgeryNeoplasm Recurrence LocalHepatectomyColorectal NeoplasmsbusinessAnnals of Surgery
researchProduct

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

2006

Item does not contain fulltext BACKGROUND: Loss of TP53 function through gene mutation is a critical event in the development and progression of many tumour types including colorectal cancer (CRC). In vitro studies have found considerable heterogeneity amongst different TP53 mutants in terms of their transactivating abilities. The aim of this work was to evaluate whether TP53 mutations classified as functionally inactive (< or=20% of wildtype transactivation ability) had different prognostic and predictive values in CRC compared with mutations that retained significant activity. MATERIALS AND METHODS: TP53 mutations within a large, international database of CRC (n = 3583) were classified ac…

Oncologyp53MaleNutrition and Diseasebinding domainsLymphovascular invasionColorectal cancerDNA Mutational AnalysisAetiology screening and detection [ONCOL 5]Gene mutationmedicine.disease_causeTransactivationVoeding en ZiekteAntineoplastic Combined Chemotherapy ProtocolsDeterminants in Health and Disease [EBP 1]transcriptional activityMutationHematologyExonsMiddle AgedSurvival RateOncologyAdenocarcinomaFemaleColorectal Neoplasmsmedicine.medical_specialtyAdenocarcinomachemotherapy colorectal cancer mutation prognosis TP53 transactivational abilityMolecular epidemiology [NCEBP 1]Breast cancerTranslational research [ONCOL 3]Interventional oncology [UMCN 1.5]Internal medicinemedicineHumansNeoplasm InvasivenessSurvival rateneoplasmsbreast-cancerVLAGAgedNeoplasm StagingHereditary cancer and cancer-related syndromes [ONCOL 1]business.industryInternational Agenciesmedicine.diseaseImmunologyMutationTumor Suppressor Protein p53businessFollow-Up Studies
researchProduct

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK …

2013

Background: Combined inhibition of platelet-derived growth factor receptor beta signalling and vascular endothelial growth factor promotes vascular normalisation in preclinical models and may lead to increased delivery of chemotherapy to tumour tissue. This phase I/II trial assessed the safety and efficacy of capecitabine plus oxaliplatin (XELOX) plus bevacizumab and imatinib in the first-line treatment of patients with metastatic colorectal cancer. Methods: Two dose levels (I/II) were defined: capecitabine 850/1000 mg m−2 twice daily on days 1–14; oxaliplatin 100/130 mg m−2 on day 1; bevacizumab 7.5 mg kg−1 on day 1; imatinib 300 mg day−1 on days 1–21 every 21 days. The primary study endpo…

OncologysafetyAdultMaleCancer Researchmedicine.medical_specialtyBevacizumabOrganoplatinum CompoundsColorectal cancermedicine.medical_treatmentcolorectal cancerbevacizumabAntibodies Monoclonal HumanizedDeoxycytidineDisease-Free SurvivalDrug Administration SchedulePiperazinesCapecitabineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansProspective StudiesCapecitabineAgedAged 80 and overChemotherapybusiness.industrySunitiniboxaliplatinMiddle Agedmedicine.diseaseSurgeryOxaliplatinImatinib mesylatePyrimidinesTreatment OutcomeOncologyimatinibFluorouracilBenzamidesClinical StudyImatinib MesylateFemaleFluorouracilbusinessColorectal Neoplasmsmedicine.drugBritish Journal of Cancer
researchProduct

Low-cost, portable open-source gas monitoring device based on chemosensory technology

2015

[EN] We report herein the construction of an electronic device to perform the real-time digitalization of the color state of the optical chemosensors used in the detection of dangerous gases. To construct the device, we used open-source modular electronics, such as Arduino and Sparkfun components, as well as free and open-source software (FOSS). The basic principle of the operation of this device is the continuous color measurement of a chemosensor-doped sensing film, whose color changes in the presence of a specific gas. The chemosensor-sensing film can be prepared by using any of the widely available chemosensors for the desired gas. Color measurement is taken by two TCS230 color sensor I…

Open-sourceLiquid-crystal displayComputer sciencebusiness.industryApplied MathematicsColorSerial portChemosensorMonitorUSBModular designlaw.inventionMicrocontrollerGaslawArduinoArduinoGas detectorElectronicsbusinessInstrumentationEngineering (miscellaneous)Computer hardwareSensorMeasurement Science and Technology
researchProduct

The Streptomyces coelicolor dnaK operon contains a second promoter driving the expression of the negative regulator hspR at physiological temperature

2006

HspR (heat shock protein regulator) acts as a negative regulator of different genes in many bacteria. In Streptomyces coelicolor hspR gene is part and the transcriptional repressor of the dnaK operon which encodes the DnaK, GrpE, DnaJ chaperone machines and HspR itself. Our experiments led us to the discovery of a second promoter, internal to dnaK operon, located upstream hspR gene. Transcription from this promoter was detected at 30 degrees C indicating that hspR could play a key physiological role.

OperonMolecular Sequence Datagenetic processesRegulatorStreptomyces coelicolorBiochemistryMicrobiologyheat shock responseBacterial ProteinsTranscription (biology)Heat shock proteinOperonGeneticsHSP70 Heat-Shock ProteinsHeat shockPromoter Regions GeneticMolecular BiologyGeneHeat-Shock ProteinsGeneticsBase SequencebiologyReverse Transcriptase Polymerase Chain ReactionStreptomyces coelicolorTemperatureGene Expression Regulation BacterialGeneral Medicinebiology.organism_classificationRepressor ProteinshspRChaperone (protein)biological sciencesbiology.proteinbacteriaArchives of Microbiology
researchProduct

Correlation between optics quality of multifocal intraocular lenses and visual acuity

2009

Purpose To study the relationship between the optics quality of multifocal intraocular lenses (IOLs) and distance-corrected near, intermediate, and distance visual acuity to determine the degree to which optics quality must change to produce a significant difference in visual acuity. Setting Fundacion Oftalmologica del Mediterraneo, Valencia, Spain. Methods Monocular distance-corrected visual acuity (decimal and logMAR) was measured at 4 m, 70 cm, and 30 cm under photopic and mesopic conditions in eyes with 1 of 3 multifocal IOL models. Visual acuity versus the “average modulation” of the IOL was assessed. Results The pupil diameter and patient age were similar between the 3 IOL groups (20 …

Optics and Photonicsmedicine.medical_specialtyVisual acuityPseudophakiagenetic structuresMesopic visionColor visionmedicine.medical_treatmentVisual AcuityIntraocular lensPupilOpticsLens Implantation IntraocularOphthalmologymedicineHumansAgedRetrospective StudiesLenses IntraocularPhacoemulsificationColor VisionFourier Analysisbusiness.industryPupilPhacoemulsificationMultifocal intraocular lenseye diseasesSensory SystemsOphthalmologyOptometrySurgerysense organsmedicine.symptombusinessPhotopic visionJournal of Cataract and Refractive Surgery
researchProduct

Color Vision 2020: Introduction by the feature editors

2020

OpticsColor constancyColor visionbusiness.industryFeature (computer vision)Computer scienceVisual opticsComputer visionComputer Vision and Pattern RecognitionArtificial intelligencebusinessAtomic and Molecular Physics and OpticsElectronic Optical and Magnetic MaterialsJournal of the Optical Society of America A
researchProduct

Assessment of efficiencies of electroporation and sonoporation methods by using fluorescence RGB imaging method

2013

Simple RGB method for fluorescence in vivo imaging is presented to assess efficiency of electroporation and sonoporation methods by measuring distribution and accumulation of green fluorescence protein (GFP) concentration. 20 laboratory measurements were performed on mice to test the method.

OpticsMaterials sciencebusiness.industryElectroporationRGB color modelbusinessFluorescenceSonoporationPreclinical imagingBiomedical engineeringGreen fluorescent proteinSPIE Proceedings
researchProduct